Cargando…
Association of Higher Advanced Oxidation Protein Products (AOPPs) Levels in Patients with Diabetic and Hypertensive Nephropathy
Background and Objectives: Diabetes mellitus (DM) and hypertension (HT) are characterized by cell damage caused by inflammatory and metabolic mechanisms induced by alteration in reduction-oxidative status. Serum advanced oxidation protein products (AOPP) are new markers of protein damage induced by...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6843920/ https://www.ncbi.nlm.nih.gov/pubmed/31591338 http://dx.doi.org/10.3390/medicina55100675 |
_version_ | 1783468329963356160 |
---|---|
author | Conti, Giovanni Caccamo, Daniela Siligato, Rossella Gembillo, Guido Satta, Ersilia Pazzano, Dario Carucci, Nicolina Carella, Antonio Del Campo, Giuliana Salvo, Antonino Santoro, Domenico |
author_facet | Conti, Giovanni Caccamo, Daniela Siligato, Rossella Gembillo, Guido Satta, Ersilia Pazzano, Dario Carucci, Nicolina Carella, Antonio Del Campo, Giuliana Salvo, Antonino Santoro, Domenico |
author_sort | Conti, Giovanni |
collection | PubMed |
description | Background and Objectives: Diabetes mellitus (DM) and hypertension (HT) are characterized by cell damage caused by inflammatory and metabolic mechanisms induced by alteration in reduction-oxidative status. Serum advanced oxidation protein products (AOPP) are new markers of protein damage induced by oxidative stress. We evaluated serum levels of AOPP in a cohort of patients with DM and HT, with or without renal complications, compared with a control healthy population. Materials and Methods: The study group comprised of 62 patients with type 2 DM and 56 with HT. The 62 patients affected by DM were further distinguished in 24 subjects without renal impairment, 18 with diabetic nephropathy (DN), 20 with chronic kidney disease (CKD) stage 2–3 secondary to DN. The subgroup of 56 patients with primary HT comprised 26 subjects without renal complications and 30 with CKD (stage 2–3) secondary to HT. Thirty healthy controls, matched for age and sex, were recruited among blood donors. Results: Increased AOPP levels were found in DM patients compared with healthy subjects, although not significantly. This index was higher and more significant in patients with DN and CKD secondary to DN than in DM patients without nephropathy (p < 0.05) or controls (p < 0.0001). Patients with HT and with kidney impairment secondary to HT also had significantly higher AOPP serum levels than controls (p < 0.01 and p < 0.0001, respectively). There were no significant differences in mean AOPP levels among DM and HT patients. Conclusion: Our study showed that oxidative stress was higher in diabetic or hypertensive subjects than in healthy controls and, in particular, it appeared to be more severe in patients with renal complications. We suggest that the assessment of AOPP in diabetic and hypertensive patients may be important to predict the onset of renal failure and to open a new perspective on the adoption of antioxidant molecules to prevent CKD in those settings. |
format | Online Article Text |
id | pubmed-6843920 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-68439202019-11-25 Association of Higher Advanced Oxidation Protein Products (AOPPs) Levels in Patients with Diabetic and Hypertensive Nephropathy Conti, Giovanni Caccamo, Daniela Siligato, Rossella Gembillo, Guido Satta, Ersilia Pazzano, Dario Carucci, Nicolina Carella, Antonio Del Campo, Giuliana Salvo, Antonino Santoro, Domenico Medicina (Kaunas) Article Background and Objectives: Diabetes mellitus (DM) and hypertension (HT) are characterized by cell damage caused by inflammatory and metabolic mechanisms induced by alteration in reduction-oxidative status. Serum advanced oxidation protein products (AOPP) are new markers of protein damage induced by oxidative stress. We evaluated serum levels of AOPP in a cohort of patients with DM and HT, with or without renal complications, compared with a control healthy population. Materials and Methods: The study group comprised of 62 patients with type 2 DM and 56 with HT. The 62 patients affected by DM were further distinguished in 24 subjects without renal impairment, 18 with diabetic nephropathy (DN), 20 with chronic kidney disease (CKD) stage 2–3 secondary to DN. The subgroup of 56 patients with primary HT comprised 26 subjects without renal complications and 30 with CKD (stage 2–3) secondary to HT. Thirty healthy controls, matched for age and sex, were recruited among blood donors. Results: Increased AOPP levels were found in DM patients compared with healthy subjects, although not significantly. This index was higher and more significant in patients with DN and CKD secondary to DN than in DM patients without nephropathy (p < 0.05) or controls (p < 0.0001). Patients with HT and with kidney impairment secondary to HT also had significantly higher AOPP serum levels than controls (p < 0.01 and p < 0.0001, respectively). There were no significant differences in mean AOPP levels among DM and HT patients. Conclusion: Our study showed that oxidative stress was higher in diabetic or hypertensive subjects than in healthy controls and, in particular, it appeared to be more severe in patients with renal complications. We suggest that the assessment of AOPP in diabetic and hypertensive patients may be important to predict the onset of renal failure and to open a new perspective on the adoption of antioxidant molecules to prevent CKD in those settings. MDPI 2019-10-07 /pmc/articles/PMC6843920/ /pubmed/31591338 http://dx.doi.org/10.3390/medicina55100675 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Conti, Giovanni Caccamo, Daniela Siligato, Rossella Gembillo, Guido Satta, Ersilia Pazzano, Dario Carucci, Nicolina Carella, Antonio Del Campo, Giuliana Salvo, Antonino Santoro, Domenico Association of Higher Advanced Oxidation Protein Products (AOPPs) Levels in Patients with Diabetic and Hypertensive Nephropathy |
title | Association of Higher Advanced Oxidation Protein Products (AOPPs) Levels in Patients with Diabetic and Hypertensive Nephropathy |
title_full | Association of Higher Advanced Oxidation Protein Products (AOPPs) Levels in Patients with Diabetic and Hypertensive Nephropathy |
title_fullStr | Association of Higher Advanced Oxidation Protein Products (AOPPs) Levels in Patients with Diabetic and Hypertensive Nephropathy |
title_full_unstemmed | Association of Higher Advanced Oxidation Protein Products (AOPPs) Levels in Patients with Diabetic and Hypertensive Nephropathy |
title_short | Association of Higher Advanced Oxidation Protein Products (AOPPs) Levels in Patients with Diabetic and Hypertensive Nephropathy |
title_sort | association of higher advanced oxidation protein products (aopps) levels in patients with diabetic and hypertensive nephropathy |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6843920/ https://www.ncbi.nlm.nih.gov/pubmed/31591338 http://dx.doi.org/10.3390/medicina55100675 |
work_keys_str_mv | AT contigiovanni associationofhigheradvancedoxidationproteinproductsaoppslevelsinpatientswithdiabeticandhypertensivenephropathy AT caccamodaniela associationofhigheradvancedoxidationproteinproductsaoppslevelsinpatientswithdiabeticandhypertensivenephropathy AT siligatorossella associationofhigheradvancedoxidationproteinproductsaoppslevelsinpatientswithdiabeticandhypertensivenephropathy AT gembilloguido associationofhigheradvancedoxidationproteinproductsaoppslevelsinpatientswithdiabeticandhypertensivenephropathy AT sattaersilia associationofhigheradvancedoxidationproteinproductsaoppslevelsinpatientswithdiabeticandhypertensivenephropathy AT pazzanodario associationofhigheradvancedoxidationproteinproductsaoppslevelsinpatientswithdiabeticandhypertensivenephropathy AT caruccinicolina associationofhigheradvancedoxidationproteinproductsaoppslevelsinpatientswithdiabeticandhypertensivenephropathy AT carellaantonio associationofhigheradvancedoxidationproteinproductsaoppslevelsinpatientswithdiabeticandhypertensivenephropathy AT delcampogiuliana associationofhigheradvancedoxidationproteinproductsaoppslevelsinpatientswithdiabeticandhypertensivenephropathy AT salvoantonino associationofhigheradvancedoxidationproteinproductsaoppslevelsinpatientswithdiabeticandhypertensivenephropathy AT santorodomenico associationofhigheradvancedoxidationproteinproductsaoppslevelsinpatientswithdiabeticandhypertensivenephropathy |